Riskpilot← Back to searchSign inGet full accessEMEDICE AS
ASActiveOrg 918285229Jåberggrenda 50, 3232 SandefjordGeneral medical practice activities · NACE 8621Est. 20160 employees
Revenue 2024
NOK 0
EBITDA margin
—
-179% vs 2023
Equity ratio
93.0%
Financial strength
Net profit 2024
NOK -184K
-203% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -181K | -179% |
| Net profit | NOK -184K | -203% |
| Total assets | NOK 261K | -56% |
| Equity | NOK 243K | -43% |
| Employees | 0 | — |
Legal name
EMEDICE AS
Org number
918285229
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
21. desember 2016
Share capital
NOK 30 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Allmenn legetjeneste samt konsulenttjenester innen helse- og omsorgssektor, e-helse, klinisk ikt, medisinsk informatikk og terminologi, kurs og veiledning, samt produksjon, import, eksport og salg av produkter og tjenester som naturlig hører til dette, herunder å delta i andre selskap med lignende virksomhet, og kjøp og salg av aksjer eller på annen måte gjøre seg interessert i andre foretak. Selskapet kan også drive med kjøp/drift av fast eiendom.
Address
Jåberggrenda 50, 3232 Sandefjord
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 912 | 807 | 1 100 | 466 | 0 |
| Staff expenses | −1 | −4 | −4 | −5 | −4 |
| EBITDA | 784 | 671 | 873 | 228 | −181 |
| Depreciation & amort. | −12 | −0 | −1 | −11 | −11 |
| EBIT | 772 | 671 | 872 | 216 | −192 |
| Net financials | 3 | 2 | 4 | 13 | 7 |
| Profit before tax | 775 | 673 | 876 | 229 | −185 |
| Tax | 170 | 148 | 193 | 51 | −1 |
| Net profit | 605 | 525 | 683 | 179 | −184 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 469 | 989 | 1 299 | 588 | 261 |
| Equity | 1 041 | 565 | 748 | 427 | 243 |
| Long-term debt | 0 | 0 | 2 | 1 | 0 |
| Short-term debt | 429 | 424 | 549 | 161 | 18 |
| Total debt | 429 | 424 | 551 | 162 | 18 |
EBITDA margin
-18089400.0%
This company
15.8%
Market median
-114489973% vs market
20202024
Equity ratio
93.0%
This company
38.2%
Market median
+143% vs market
20202024
Return on equity
-75.8%
This company
18.4%
Market median
-512% vs market
20202024
Net profit margin
-18401600.0%
This company
8.1%
Market median
-227180347% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.08×
This company
0.62×
Market median
+87% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AR Deputy Member | Deputy Member | 2016 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2016 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of EMEDICE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Arnt Ree | Deputy Member | 0 companies |
| Arnt Ole Ree | Chairman | 0 companies |